121 related articles for article (PubMed ID: 25915745)
1. Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial.
Trajman A; Durovni B; Saraceni V; Menezes A; Cordeiro-Santos M; Cobelens F; Van den Hof S
PLoS One; 2015; 10(4):e0123252. PubMed ID: 25915745
[TBL] [Abstract][Full Text] [Related]
2. Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda.
Ssengooba W; de Dieu Iragena J; Komakech K; Okello I; Nalunjogi J; Katagira W; Kimuli I; Adakun S; Joloba ML; Torrea G; Kirenga BJ
Open Forum Infect Dis; 2021 Jun; 8(6):ofab173. PubMed ID: 34189166
[TBL] [Abstract][Full Text] [Related]
3. Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE).
Leukes VN; Hella J; Sabi I; Cossa M; Khosa C; Erkosar B; Mangu C; Siyame E; Mtafya B; Lwilla A; Viegas S; Madeira C; Machiana A; Ribeiro J; Garcia-Basteiro AL; Riess F; Elísio D; Sasamalo M; Mhalu G; Denkinger CM; Castro MDM; Bashir S; Schumacher SG; Tagliani E; Malhotra A; Dowdy D; Schacht C; Buech J; Nguenha D; Ntinginya N; Ruhwald M; Penn-Nicholson A; Kranzer K;
BMC Infect Dis; 2024 Jan; 24(1):107. PubMed ID: 38243223
[TBL] [Abstract][Full Text] [Related]
4. Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL): A cross-sectional observational study protocol using respondent driven sampling.
Carney T; Rooney JA; Niemand N; Myers B; Theron D; Wood R; White LF; Meade CS; Chegou NN; Ragan E; Walzl G; Horsburgh R; Warren RM; Jacobson KR
PLoS One; 2022; 17(2):e0262440. PubMed ID: 35167586
[TBL] [Abstract][Full Text] [Related]
5. Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.
Cattamanchi A; Reza TF; Nalugwa T; Adams K; Nantale M; Oyuku D; Nabwire S; Babirye D; Turyahabwe S; Tucker A; Sohn H; Ferguson O; Thompson R; Shete PB; Handley MA; Ackerman S; Joloba M; Moore DAJ; Davis JL; Dowdy DW; Fielding K; Katamba A
N Engl J Med; 2021 Dec; 385(26):2441-2450. PubMed ID: 34936740
[TBL] [Abstract][Full Text] [Related]
6. Time series of cases and treatment outcomes from tuberculosis in Sergipe, 2012-2021.
Batista JFC; Santos VSO; Jesus CVF; Lima SO
Rev Bras Epidemiol; 2023; 26():e230041. PubMed ID: 37729348
[TBL] [Abstract][Full Text] [Related]
7. Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis.
Drobniewski F; Cooke M; Jordan J; Casali N; Mugwagwa T; Broda A; Townsend C; Sivaramakrishnan A; Green N; Jit M; Lipman M; Lord J; White PJ; Abubakar I
Health Technol Assess; 2015 May; 19(34):1-188, vii-viii. PubMed ID: 25952553
[TBL] [Abstract][Full Text] [Related]
8. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
Sachdeva KS; Raizada N; Sreenivas A; Van't Hoog AH; van den Hof S; Dewan PK; Thakur R; Gupta RS; Kulsange S; Vadera B; Babre A; Gray C; Parmar M; Ghedia M; Ramachandran R; Alavadi U; Arinaminpathy N; Denkinger C; Boehme C; Paramasivan CN
PLoS One; 2015; 10(5):e0126065. PubMed ID: 25996389
[TBL] [Abstract][Full Text] [Related]
9. Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India.
Little KM; Pai M; Dowdy DW
PLoS One; 2014; 10(4):e0124525. PubMed ID: 25918999
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone Therapy for the Prevention of Multidrug-Resistant Tuberculosis in Contacts. A Cost-Effectiveness Analysis.
Fox GJ; Oxlade O; Menzies D
Am J Respir Crit Care Med; 2015 Jul; 192(2):229-37. PubMed ID: 25915791
[TBL] [Abstract][Full Text] [Related]
11. Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF.
Churchyard GJ; Stevens WS; Mametja LD; McCarthy KM; Chihota V; Nicol MP; Erasmus LK; Ndjeka NO; Mvusi L; Vassall A; Sinanovic E; Cox HS; Dye C; Grant AD; Fielding KL
Lancet Glob Health; 2015 Aug; 3(8):e450-e457. PubMed ID: 26187490
[TBL] [Abstract][Full Text] [Related]
12. Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries.
Abdurrahman ST; Mbanaso O; Lawson L; Oladimeji O; Blakiston M; Obasanya J; Dacombe R; Adams ER; Emenyonu N; Sahu S; Creswell J; Cuevas LE
J Clin Microbiol; 2015 Aug; 53(8):2502-8. PubMed ID: 26019204
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.
Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L
PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339
[TBL] [Abstract][Full Text] [Related]
14. Identifying areas and risk groups with localised Mycobacterium tuberculosis transmission in northern England from 2010 to 2012: spatiotemporal analysis incorporating highly discriminatory genotyping data.
Saavedra-Campos M; Welfare W; Cleary P; Sails A; Burkitt A; Hungerford D; Okereke E; Acheson P; Petrovic M
Thorax; 2016 Aug; 71(8):742-8. PubMed ID: 25920328
[TBL] [Abstract][Full Text] [Related]
15. Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials?
Auld AF; Fielding KL; Gupta-Wright A; Lawn SD
Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):432-44. PubMed ID: 27638038
[TBL] [Abstract][Full Text] [Related]
16. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM
Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036
[TBL] [Abstract][Full Text] [Related]
17. Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.
Cox H; Ramma L; Wilkinson L; Azevedo V; Sinanovic E
Trop Med Int Health; 2015 Oct; 20(10):1337-45. PubMed ID: 25975868
[TBL] [Abstract][Full Text] [Related]
18. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
Laurence YV; Griffiths UK; Vassall A
Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
[TBL] [Abstract][Full Text] [Related]
19. Institutional Tuberculosis Transmission. Controlled Trial of Upper Room Ultraviolet Air Disinfection: A Basis for New Dosing Guidelines.
Mphaphlele M; Dharmadhikari AS; Jensen PA; Rudnick SN; van Reenen TH; Pagano MA; Leuschner W; Sears TA; Milonova SP; van der Walt M; Stoltz AC; Weyer K; Nardell EA
Am J Respir Crit Care Med; 2015 Aug; 192(4):477-84. PubMed ID: 25928547
[TBL] [Abstract][Full Text] [Related]
20. Global Tuberculosis Control: Toward the 2015 Targets and Beyond.
Dirlikov E; Raviglione M; Scano F
Ann Intern Med; 2015 Jul; 163(1):52-8. PubMed ID: 25915859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
